Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Higher doses of semaglutide (2.4 mg weekly, Wegovy) have been specifically licensed for weight management in individuals with obesity, reflecting the medication's potent effects on appetite regulation
Participants in the trial taking tirzepatide instead of the placebo achieved average weight reductions of 16% (or 35 pounds) with a 5-milligram dose, 21.4% (or 49 pounds) on a 10-milligram dose, and 22.5% (or 52 pounds) on a 15-milligram dose
doi:10.1002/cpt.1307 10
However, depending on your symptoms and the state of your hormones, there may be alternative hormone therapies that are better-suited for your needs
US$ 20.49
US$ 22.98
US$ 24.10
US$ 25.50
US$ 27.27
